David M. Ota - Concepedia

Author

David M. Ota

The University of Texas MD Anderson Cancer Center

Also Known As

Creighton, Chad J., D M Ota, D OTA, D Ota, D. M. Ota, D. OTA, D. Ota, D.M. Ota, DAVID M. OTA, DAVID OTA

148

Publications

7.9K

Citations

H-Index

100

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Anderson Hospital Duke University Mayo Clinic Society of Surgical Oncology

About

David M. Ota is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	51	4.5K
2	Health Sciences	5	5	1K
3	Public Health	2	2	71
4	Education	1	1	176
5	Natural Sciences	1	1	14

David M. Ota

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Whole-genome analysis informs breast cancer response to aromatase inhibition Matthew J. Ellis, Li Ding, Dong Shen, Nature	2012	1K
Complications and Failures of Subclavian-Vein Catheterization Paul F. Mansfield, David C. Hohn, Bruno D. Fornage, New England Journal of Medicine Venous DiseaseCentral Venous CathetersPatient SafetyVascular SurgeryThoracic Surgery	1994	710
Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2 Jan Heidemann, Hitoshi Ogawa, Michael B. Dwinell, Journal of Biological Chemistry InflammationCytokineAngiogenesisEndothelial CellsMucosal Immunology	2003	471
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance) Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Journal of Clinical Oncology	2017	403
13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin S. M. Lippman, David Parkinson, Loretta M. Itri, JNCI Journal of the National Cancer Institute	1992	395
MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Shoji Nakamori, David M. Ota, Karen R. Cleary, Gastroenterology Tumor BiologyMedicineColorectal CancerPathologyCancer Biology	1994	282
Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer Tyvin A. Rich, John M. Skibber, Jaffer A. Ajani, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyColorectal SurgeryMedicineSurgeryOncology	1995	281
Radiofrequency ablation of liver tumors: Influence of technique and tumor size Boris W. Kuvshinoff, David M. Ota Surgery Surgical OncologyHepatologyRadiofrequency AblationMedicineTumor Size	2002	223
Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Stuart D. Hoff, Yosuke Matsushita, David M. Ota, PubMed ImmunologyPathologyLiver MetastasesTumor BiologyOncology	1989	194
Virtual reality in surgical education David M. Ota, Bowen Loftin, Tim Saito, Computers in Biology and Medicine Virtual RealitySurgical TrainingImmersive TechnologyEducationSurgery Simulator	1995	176

Page 1